: Biogen stock slips after FDA approves first biosimilar to Tysabri MS treatment
Biogen Inc. BIIB shares slipped in the extended session Thursday after the Food and Drug Administration granted a soon-to-be Novartis AG NVS spinoff approval for...
: ‘Dune: Part Two’ pushed to 2024 because of Hollywood strikes
Legendary Entertainment and Warner Bros. Discovery Inc.’s WBD blockbuster sequel, “Dune: Part Two” from director Denis Villeneuve, has been pushed to a theatrical release date...
: Dow sheds 300 points as stocks see biggest drop in 3 weeks
U.S. stocks logged their biggest drop in three weeks on Thursday with losses accelerating into the close as rising Treasury yields and a stronger U.S....
: Nvidia’s stock closes marginally higher, but just short of a record
Nvidia Corp. NVDA shares failed to close at a record high Thursday after the AI-chip maker’s stellar earnings report initially boosted shares past $500 for...
: Workday’s stock is rising after another quarterly earnings beat
Workday Inc. WDAY stock climbed 4.5% in extended trading Thursday after the company reported quarterly results that edged the estimates of analysts. Workday reported fiscal...